Pay in 4 interest-free payments of $5.15 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
The pathophysiological nexus between MASLD and CVD is driven by shared metabolic risk factors such as insulin resistance, dyslipidaemia, and chronic low-grade inflammation which collectively promote endothelial dysfunction, atherogenesis, and myocardial remodeling 7
Strategies that help throughout treatment include eating smaller meals, avoiding fatty foods, staying hydrated, and eating slowly
For example, the LEADER trial showed that liraglutide reduced MACEs risk by 13%, while the SUSTAIN-6 trial indicated a 26% reduction with semaglutide
Choose what works best for your routine
Personalized plans, everyone is different and we want to ensure you see minimal or no side effects with maximum weight loss
